FDA approves first drug that delays onset of type 1 diabetes
Thanks in part to Yale-led clinical trials, the FDA recently approved teplizumab, the first drug with the ability to change the course of type 1 diabetes.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Health | Science | Universities & Medical Training | Yale